This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Synergy Pharmaceuticals Inc (SGYP)

NASDAQ: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash and Equivalents 146.47M 18.13M 12.42M 13.24M
Receivables 0.00 0.00 0.00 0.00
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 0.00 0.00 20.09M 0.00
Total Current Assets 200.20M 71.88M 34.05M 14.31M
Property, Plant & Equipment, Gross 865.00K 692.00K 77.00K 50.54K
Accumulated Depreciation & Depletion 223.00K 103.00K 47.00K 44.76K
Property, Plant & Equipment, Net 642.00K 589.00K 30.00K 5.77K
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 12.50M 94.00K 3.33M 1.56M
Total Non-Current Assets 13.14M 683.00K 3.36M 1.56M
Liabilities & Shareholder Equity
Total Assets 213.34M 72.56M 37.40M 15.87M
Accounts Payable 13.87M 13.54M 5.26M 1.42M
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 0.00 0.00 0.00 0.00
Total Current Liabilities 18.33M 15.68M 7.32M 2.75M
Long Term Debt 200.00M 0.00 0.00 0.00
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 172.00K 1.53M 5.26M 3.33M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 200.17M 1.53M 5.26M 3.33M
Total Liabilities 218.50M 17.21M 12.57M 6.07M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity -5.16M 55.35M 24.83M 9.80M
Common Par 11.00K 10.00K 7.00K 5.43K
Additional Paid In Capital 261.72M 226.52M 133.88M 79.40M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -266.88M -171.18M -109.05M -69.61M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 0.00 0.00 0.00 0.00
Total Capitalization 194.84M 55.35M 24.83M 9.80M
Total Equity -5.16M 55.35M 24.83M 9.80M
Total Liabilities & Stock Equity 213.34M 72.56M 37.40M 15.87M
Total Common Shares Outstanding 96.61M 90.18M 66.62M 54.28M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 94.28M 85.22M 61.70M 47.60M
Diluted Weighted Shares Outstanding 94.28M 85.22M 61.70M 47.60M
Number of Employees 35 25 18 9
Number of Part-Time Employees 0 0 0 1

SGYP Synergy Pharmaceuticals Inc

Chart of SGYP

Analysts Ratings for SGYP

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 1 2 2 2
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

Brokerage Partners

SGYP Chatter

Select the service that is right for you!

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs